Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Anesthesia for Trigeminal-Cardiac Reflex in Retinoblastoma
NCT02955524Phase 1Withdrawn
- Sponsor
- University of Miami
- Start
- Mar 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tetracaine and lidocaine 10% oropharyngeal spray in Trigeminocardiac Reflex (TCR), sponsored by University of Miami. Primary endpoints: Decrease in systolic Blood Pressure, Drop in end-tidal CO2 and 3 more. Planned start Mar 2018; status: withdrawn.
02
Drugs
tetracainelidocaine 10% oropharyngeal spray
03
Conditions
Trigeminocardiac Reflex (TCR)
Beyond the preview
Go deeper on NCT02955524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955524.